Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · IEX Real-Time Price · USD
3.860
+0.310 (8.73%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Summit Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
105
Market Cap
2.71B USD

Revenue Chart

* The company reports in GBP currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 2022705.00K-1.10M-61.03%
Dec 31, 20211.81M949.00K110.35%
Dec 31, 2020860.00K--
Dec 31, 2019---
Jan 31, 201957.09M41.64M269.50%
Jan 31, 201815.45M12.57M436.46%
Jan 31, 20172.88M--
Jan 31, 20160--
Jan 31, 20150--
Jan 31, 20140--
Jan 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
QuidelOrtho 3.00B
Neogen 929.24M
ACADIA Pharmaceuticals 726.44M
Certara 354.34M
MorphoSys AG 264.75M
Arrowhead Pharmaceuticals 181.74M
PROCEPT BioRobotics 136.19M
Arcellx 110.32M
Revenue Rankings